Literature DB >> 33720040

Neutrophil dynamics in the tumor microenvironment.

Amanda J McFarlane1, Frédéric Fercoq1, Seth B Coffelt1,2, Leo M Carlin1,2.   

Abstract

The tumor microenvironment profoundly influences the behavior of recruited leukocytes and tissue-resident immune cells. These immune cells, which inherently have environmentally driven plasticity necessary for their roles in tissue homeostasis, dynamically interact with tumor cells and the tumor stroma and play critical roles in determining the course of disease. Among these immune cells, neutrophils were once considered much more static within the tumor microenvironment; however, some of these earlier assumptions were the product of the notorious difficulty in manipulating neutrophils in vitro. Technological advances that allow us to study neutrophils in context are now revealing the true roles of neutrophils in the tumor microenvironment. Here we discuss recent data generated by some of these tools and how these data might be synthesized into more elegant ways of targeting these powerful and abundant effector immune cells in the clinic.

Entities:  

Mesh:

Year:  2021        PMID: 33720040      PMCID: PMC7954585          DOI: 10.1172/JCI143759

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  167 in total

1.  IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D.

Authors:  Mohamed Lamkanfi; Jo A Van Ginderachter; Damya Laoui; Máté Kiss; Lieselotte Vande Walle; Pedro H V Saavedra; Els Lebegge; Helena Van Damme; Aleksandar Murgaski; Junbin Qian; Manuel Ehling; Samantha Pretto; Evangelia Bolli; Jiri Keirsse; Pauline M R Bardet; Sana M Arnouk; Yvon Elkrim; Maryse Schmoetten; Jan Brughmans; Ayla Debraekeleer; Amelie Fossoul; Louis Boon; Geert Raes; Geert van Loo; Diether Lambrechts; Massimiliano Mazzone; Alain Beschin; Andy Wullaert
Journal:  Cancer Immunol Res       Date:  2020-12-23       Impact factor: 11.151

2.  Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.

Authors:  Jean Albrengues; Mario A Shields; David Ng; Chun Gwon Park; Alexandra Ambrico; Morgan E Poindexter; Priya Upadhyay; Dale L Uyeminami; Arnaud Pommier; Victoria Küttner; Emilis Bružas; Laura Maiorino; Carmelita Bautista; Ellese M Carmona; Phyllis A Gimotty; Douglas T Fearon; Kenneth Chang; Scott K Lyons; Kent E Pinkerton; Lloyd C Trotman; Michael S Goldberg; Johannes T-H Yeh; Mikala Egeblad
Journal:  Science       Date:  2018-09-28       Impact factor: 47.728

3.  CD177+ neutrophils suppress epithelial cell tumourigenesis in colitis-associated cancer and predict good prognosis in colorectal cancer.

Authors:  Guangxi Zhou; Kangsheng Peng; Yang Song; Wenjing Yang; Weigang Shu; Tianming Yu; Lin Yu; Moubin Lin; Qing Wei; Chunqiu Chen; Lu Yin; Yingzi Cong; Zhanju Liu
Journal:  Carcinogenesis       Date:  2018-02-09       Impact factor: 4.944

4.  Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects.

Authors:  Roni F Rayes; Jack G Mouhanna; Ioana Nicolau; France Bourdeau; Betty Giannias; Simon Rousseau; Daniela Quail; Logan Walsh; Veena Sangwan; Nicholas Bertos; Jonathan Cools-Lartigue; Lorenzo E Ferri; Jonathan D Spicer
Journal:  JCI Insight       Date:  2019-07-25

5.  Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer.

Authors:  Yunwei Han; Zhihao Yu; Shaoyan Wen; Bin Zhang; Xuchen Cao; Xin Wang
Journal:  Breast Cancer Res Treat       Date:  2011-10-05       Impact factor: 4.872

Review 6.  Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.

Authors:  Arnoud J Templeton; Mairéad G McNamara; Boštjan Šeruga; Francisco E Vera-Badillo; Priya Aneja; Alberto Ocaña; Raya Leibowitz-Amit; Guru Sonpavde; Jennifer J Knox; Ben Tran; Ian F Tannock; Eitan Amir
Journal:  J Natl Cancer Inst       Date:  2014-05-29       Impact factor: 13.506

7.  Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms.

Authors:  Jinming Yang; Amrendra Kumar; Anna E Vilgelm; Sheau-Chiann Chen; Gregory D Ayers; Sergey V Novitskiy; Sebastian Joyce; Ann Richmond
Journal:  Cancer Immunol Res       Date:  2018-08-14       Impact factor: 11.151

8.  Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer.

Authors:  Evgeniy B Eruslanov; Pratik S Bhojnagarwala; Jon G Quatromoni; Tom Li Stephen; Anjana Ranganathan; Charuhas Deshpande; Tatiana Akimova; Anil Vachani; Leslie Litzky; Wayne W Hancock; José R Conejo-Garcia; Michael Feldman; Steven M Albelda; Sunil Singhal
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

9.  Neutrophils dominate the immune cell composition in non-small cell lung cancer.

Authors:  Julia Kargl; Stephanie E Busch; Grace H Y Yang; Kyoung-Hee Kim; Mark L Hanke; Heather E Metz; Jesse J Hubbard; Sylvia M Lee; David K Madtes; Martin W McIntosh; A McGarry Houghton
Journal:  Nat Commun       Date:  2017-02-01       Impact factor: 14.919

10.  The role of neutrophil myeloperoxidase in models of lung tumor development.

Authors:  Amy L Rymaszewski; Everett Tate; Joannes P Yimbesalu; Andrew E Gelman; Jason A Jarzembowski; Hao Zhang; Kirkwood A Pritchard; Haris G Vikis
Journal:  Cancers (Basel)       Date:  2014-05-09       Impact factor: 6.639

View more
  7 in total

Review 1.  Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis.

Authors:  Maria Teresa Palano; Matteo Gallazzi; Martina Cucchiara; Andrea De Lerma Barbaro; Daniela Gallo; Barbara Bassani; Antonino Bruno; Lorenzo Mortara
Journal:  Vaccines (Basel)       Date:  2021-12-16

2.  CXCL5: A coachman to drive cancer progression.

Authors:  Jie Deng; Rongqi Jiang; Enqing Meng; Hao Wu
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738

Review 3.  Radiotherapy combined with immunotherapy: the dawn of cancer treatment.

Authors:  Zengfu Zhang; Xu Liu; Dawei Chen; Jinming Yu
Journal:  Signal Transduct Target Ther       Date:  2022-07-29

4.  The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors.

Authors:  Li Chen; Ruihu Zhao; Hao Sun; Rong Huang; Hongming Pan; Yanjiao Zuo; Lele Zhang; Yingwei Xue; Xingrui Li; Hongjiang Song
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

Review 5.  Tumor microenvironment: barrier or opportunity towards effective cancer therapy.

Authors:  Aadhya Tiwari; Rakesh Trivedi; Shiaw-Yih Lin
Journal:  J Biomed Sci       Date:  2022-10-17       Impact factor: 12.771

Review 6.  Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance.

Authors:  Daiyong Deng; Riya Patel; Cheng-Yao Chiang; Pingping Hou
Journal:  Cells       Date:  2022-09-21       Impact factor: 7.666

7.  Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma.

Authors:  Xianbin Wu; Runkun Han; Yanping Zhong; Nuoqing Weng; Ao Zhang
Journal:  Cancer Cell Int       Date:  2021-07-07       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.